Abstract
Gemini surfactant-lipid cationic nanoparticles (NP) and electroporation (EP) with a novel tape-electrode were evaluated in mice as topical delivery methods for plasmid DNA encoding luciferase reporter gene or interferon gamma (IFNg). NP treatment of the skin without EP (dose: 25 microgram plasmid DNA/50 microliter formulation) enhanced skin expression of IFNg, three-fold compared to buffer control or topical plasmid solution, whereas application of the noninvasive tape-probe to deliver the electroporative effect after topical NP treatment decreased gene expression compared with topical NP treatment alone. Gemini NPs are a potential topical gene delivery system, however subsequent use of EP showed an inhibitory effect.
Keywords: Electroporation, gene therapy, nanoparticles, non-viral, plasmid, skin, topical, Gemini surfactant-lipid cationic nanoparticles, NP treatment
Drug Delivery Letters
Title: Topical Gene Delivery in Mice Using Gemini Surfactant - Lipid Nanoparticles With and Without Tape Electrode Electroporation
Volume: 1 Issue: 1
Author(s): I. Badea, N. Shaterian and M. Foldvari
Affiliation:
Keywords: Electroporation, gene therapy, nanoparticles, non-viral, plasmid, skin, topical, Gemini surfactant-lipid cationic nanoparticles, NP treatment
Abstract: Gemini surfactant-lipid cationic nanoparticles (NP) and electroporation (EP) with a novel tape-electrode were evaluated in mice as topical delivery methods for plasmid DNA encoding luciferase reporter gene or interferon gamma (IFNg). NP treatment of the skin without EP (dose: 25 microgram plasmid DNA/50 microliter formulation) enhanced skin expression of IFNg, three-fold compared to buffer control or topical plasmid solution, whereas application of the noninvasive tape-probe to deliver the electroporative effect after topical NP treatment decreased gene expression compared with topical NP treatment alone. Gemini NPs are a potential topical gene delivery system, however subsequent use of EP showed an inhibitory effect.
Export Options
About this article
Cite this article as:
Badea I., Shaterian N. and Foldvari M., Topical Gene Delivery in Mice Using Gemini Surfactant - Lipid Nanoparticles With and Without Tape Electrode Electroporation, Drug Delivery Letters 2011; 1 (1) . https://dx.doi.org/10.2174/2210304x11101010062
DOI https://dx.doi.org/10.2174/2210304x11101010062 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Understanding Nutritional Interventions and Physical Exercise in Non-Alcoholic Fatty Liver Disease
Current Molecular Medicine Technological Maturity and Systematic Review of Medicinal Plants with Pharmacological Activity in the Central Nervous System
Recent Patents on Biotechnology Drug Delivery from Therapeutic Self-Assembled Monolayers (T-SAMs) on 316L Stainless Steel
Current Topics in Medicinal Chemistry Withdrawal Notice: Synergistic Effect of Myricetin and Phenolic Acid Derivatives on the Reversal of Dengue Fever Related Thrombocytopenia and its Pharmacokinetics study in Plasma by using HPLC and UPLC-Q-TOF
Current Drug Metabolism The Role and Predictive Value of Cytokines in Atherosclerosis and Coronary Artery Disease
Current Medicinal Chemistry The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
Current Pharmaceutical Design Analytical Methods for Determination of ·NO and ·NO2 and their Applicability in Biological Studies
Current Pharmaceutical Analysis Protocatechuic Acid and Human Disease Prevention: Biological Activities and Molecular Mechanisms
Current Medicinal Chemistry Antiviral Therapy of Chronic Hepatitis B with Nucleotide Analogs
Anti-Infective Agents in Medicinal Chemistry Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile
Current Cancer Drug Targets Impact of Heavy Metals on Host Cells: Special Focus on Nickel-Mediated Pathologies and Novel Interventional Approaches
Endocrine, Metabolic & Immune Disorders - Drug Targets Uterine Wound Healing: A Complex Process Mediated by Proteins and Peptides
Current Protein & Peptide Science Preclinical Pharmacokinetics: An Approach Towards Safer and Efficacious Drugs
Current Drug Metabolism TGFb and its Smad Connection to Cancer
Current Genomics Genetically Modified Cellular Vaccines for Therapy of Human Papilloma Virus Type 16 (HPV 16)-Associated Tumours
Current Cancer Drug Targets Synaptic Plasticity, Dementia and Alzheimer Disease
CNS & Neurological Disorders - Drug Targets New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry Alkaloids and Flavonoids as α1-Adrenergic Receptor Antagonists
Current Medicinal Chemistry Rapid Non-genomic Vasodilator Actions of Oestrogens and Sex Steroids
Current Medicinal Chemistry The Role of B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Tumor Differentiation, Disease status and the Presence of Metastases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)